Climb Bio, Inc. (CLYM)
NASDAQ: CLYM · Real-Time Price · USD
1.180
-0.080 (-6.35%)
At close: Jun 27, 2025, 4:00 PM
1.239
+0.059 (5.03%)
After-hours: Jun 27, 2025, 7:59 PM EDT
Climb Bio Market Cap
Climb Bio has a market cap or net worth of $79.74 million as of June 27, 2025. Its market cap has decreased by -69.05% in one year.
Market Cap
79.74M
Enterprise Value
-117.63M
1-Year Change
-69.05%
Ranking
Category
Stock Price
1.18
Market Cap Chart
Since August 10, 2021, Climb Bio's market cap has decreased from $403.20M to $79.74M, a decrease of -80.22%. That is a compound annual growth rate of -34.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2025 | 85.15M | -29.63% |
| Dec 31, 2024 | 121.00M | 62.54% |
| Dec 29, 2023 | 74.45M | -23.65% |
| Dec 30, 2022 | 97.50M | -64.90% |
| Dec 31, 2021 | 277.76M | -31.11% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 696.15B |
| Johnson & Johnson | 366.71B |
| AbbVie | 322.03B |
| Novo Nordisk | 304.96B |
| UnitedHealth Group | 280.41B |
| Novartis AG | 235.85B |
| Abbott Laboratories | 233.80B |
| AstraZeneca | 220.36B |